Your session is about to expire
← Back to Search
Antimicrobial Coating
Silver-Coated Catheter for UTI Prevention
N/A
Waitlist Available
Led By Jennifer Yeung, DO
Research Sponsored by TriHealth Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 4 weeks
Awards & highlights
Study Summary
This trialaims to see if coating a catheter in silver stops urinary tract infections after pelvic surgery.
Who is the study for?
This trial is for women needing a catheter after pelvic surgery who aren't pregnant, don't have an active UTI or recent bladder injury, and haven't been treated for recurrent UTIs or interstitial cystitis in the past 3 months. Participants must be able to remove the catheter themselves at home and understand English.Check my eligibility
What is being tested?
The study aims to see if silver-coated urinary catheters can reduce infections compared to standard ones in women with urinary retention after pelvic surgery. It will also look at different bacteria causing infections and any adverse symptoms from using the silver-coated catheter.See study design
What are the potential side effects?
Possible side effects may include discomfort or irritation where the catheter enters the body, allergic reactions if sensitive to silver, and other unspecified symptoms related to using a silver-coated versus standard urinary catheter.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approximately 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 4 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of UTIs requiring treatment
Secondary outcome measures
Adverse symptoms possibly causes by silver-coated catheter
Assess the types of bacterial uropathogens isolated from the urine cultures
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Silver-Coated CatheterActive Control1 Intervention
Group II: Standard CatheterPlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
TriHealth Inc.Lead Sponsor
95 Previous Clinical Trials
50,658 Total Patients Enrolled
Jennifer Yeung, DOPrincipal InvestigatorTriHealth Inc.
1 Previous Clinical Trials
100 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing and able to participate in the study.I currently have a urinary tract infection.I have been treated for UTI or interstitial cystitis in the last 3 months.You have a known allergy to silver metal.You have a condition that makes it difficult for you to notice or understand symptoms of a urinary tract infection.I have had a bladder injury during surgery.I need a catheter after surgery for pelvic organ prolapse or urinary incontinence and failed a voiding test.
Research Study Groups:
This trial has the following groups:- Group 1: Silver-Coated Catheter
- Group 2: Standard Catheter
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there currently an open enrollment period for this experiment?
"As indicated on clinicaltrials.gov, this trial is actively enrolling participants with the initial posting having been made on June 14th 2022 and a recent update posted on November 7th 2022."
Answered by AI
How many participants are currently participating in this scientific experiment?
"Affirmative. Clinicaltrials.gov contains information that confirms this medical trial is presently in the recruitment process, which began on June 14th 2022 and was most recently revised November 7th 2022. A total of 310 participants are needed across 2 sites."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger